NRC validates Transcend
VANCOUVER, British
, Apr 14, 2011 (GlobeNewswire via COMTEX News Network) --
biOasisTechnologies Inc. (TSX-V:BTI) has received experimental results fromresearch performed on behalf of the Company by the National ResearchCouncil of ("NRC"). This work was performed for the purpose of providingindependent confirmation of results generated in prior work conducted bythe Company.
The NRC study used the Company's Transcend carriercoupled to a dye that is visible during imaging procedures. Thedye-labeled Transcend carrier was administered and observed using realtime imaging as it crossed the blood-brain barrier and migrated insidethe brain cells. The imaging dye that was used is larger than typicalsmall molecule drugs providing further evidence that the Transcendcarrier has the potential to deliver a variety of therapeutic agents ofsmall and large molecular weight across the blood-brain barrier and intothe tissue of the brain.